Northwire Canada EditionWednesday, July 15, 2026
Northwire
EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0% EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0%
Financings

Organto Foods Announces Increase in Size of Private Placement Financing to $8.0 Million

OGO · Price

Executive Summary

  • Organto Foods Inc. has increased the size of its previously announced non-brokered private placement from 14,000,000 units to 16,000,000 units due to strong investor demand.
  • The financing remains priced at $0.50 per unit, increasing the total gross proceeds from $7,000,000 to $8,000,000.
  • Net proceeds will be used to grow organic and fairtrade product lines, develop the company's technology platform, and support general working capital.

Key Details

  • Transaction Structure: Non-brokered private placement of up to 16,000,000 Units.
  • Price: $0.50 per Unit.
  • Gross Proceeds: Increased to $8,000,000 (up from $7,000,000).
  • Unit Composition: Each Unit consists of one Common Share and one-half Common Share Purchase Warrant.
  • Warrant Terms:
    • Exercise Price: $0.75 per Common Share.
    • Term: 18 months from issuance.
    • Acceleration Rights: Warrants accelerate if the share price reaches or exceeds C$1.00 for ten consecutive trading days.
  • Use of Proceeds:
    • Growth of organic and fairtrade fruit and vegetable products.
    • Further development of the Company's technology platform.
    • General working capital requirements.
  • Regulatory Conditions: Completion is subject to approval by the TSX Venture Exchange.
  • Hold Periods:
    • Common Shares and Warrants: Four months and one day from issuance under Canadian securities laws.
    • Contractual Restriction: Twelve-month restriction on transfer for all common shares and warrants, commencing on the date of issuance.
    • Warrant Exercise Shares: Common shares issued upon exercise of warrants are subject to a four-month hold period and a twelve-month contractual restriction from the date the warrants were issued.

Notable Quotes

  • "The plan to increase the size of the Private Placement is the result of strong investor demand and reflects continued confidence in Organto's growth strategy." — Steve Bromley, Co-Chair and CEO
Read the original news release →

More from Organto Foods Inc.